Published in Nephrology (Carlton) on April 01, 2005
Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol (2009) 1.43
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol (2011) 1.36
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Adverse outcomes among Aboriginal patients receiving peritoneal dialysis. CMAJ (2010) 1.11
The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol (2012) 1.02
Risk factors associated with peritoneal-dialysis-related peritonitis. Int J Nephrol (2012) 0.95
Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia. Pediatr Nephrol (2010) 0.92
Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes. Perit Dial Int (2012) 0.91
The association between peritoneal dialysis modality and peritonitis. Clin J Am Soc Nephrol (2014) 0.86
Peritoneal dialysis in rural Australia. BMC Nephrol (2013) 0.84
Association of modality with mortality among Canadian Aboriginals. Clin J Am Soc Nephrol (2012) 0.82
Peritonitis and exit site infections in First Nations patients on peritoneal dialysis. Clin J Am Soc Nephrol (2010) 0.81
Risk factors for the first episode of peritonitis in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One (2014) 0.81
Frequency and microbiology of peritonitis and exit-site infection among obese peritoneal dialysis patients. Perit Dial Int (2012) 0.80
Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLoS One (2013) 0.80
Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years' experience in a single center. Perit Dial Int (2013) 0.78
Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: A retrospective study. Medicine (Baltimore) (2016) 0.75
Outcomes of a peritoneal dialysis program in remote communities within Colombia. Perit Dial Int (2014) 0.75
Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol (2016) 0.75
Is female sex really a risk factor for infectious death in peritoneal dialysis? Perit Dial Int (2013) 0.75
Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin. Aust J Rural Health (2014) 0.75
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics (2014) 3.52
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97
Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89
Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int (2002) 1.84
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2013) 1.77
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Clinical practice guidelines for peritoneal access. Perit Dial Int (2010) 1.71
Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) (2012) 1.61
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med (2005) 1.60
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev (2009) 1.58
Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol (2014) 1.57
Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant (2004) 1.56
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation (2004) 1.52
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med (2003) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Post-kidney transplant weight change as marker of poor survival outcomes. Transplantation (2008) 1.46
Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics (2009) 1.45
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int (2010) 1.45
Waiting time and outcome of kidney transplantation in adolescents. Transplantation (2006) 1.44
Nebulized epinephrine for croup in children. Cochrane Database Syst Rev (2011) 1.43
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) (2011) 1.41
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol (2003) 1.41
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Racial disparities in pediatric kidney transplantation in New Zealand. Pediatr Transplant (2014) 1.38
Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice. Transplantation (2003) 1.38
Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2004) 1.38
Croup in the paediatric emergency department. Paediatr Child Health (2007) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int (2009) 1.34
Review article: Hepatitis B and dialysis. Nephrology (Carlton) (2010) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol (2009) 1.30
Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol (2012) 1.30
The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant (2008) 1.27
Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation (2007) 1.26
Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2010) 1.24
Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant (2010) 1.24
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant (2011) 1.23
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23
Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int (2010) 1.22
Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis. Nephrology (Carlton) (2012) 1.20
Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation (2005) 1.20
A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One (2010) 1.18